CancerVAX Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Crowdfunding
  • (Announced)

  • Latest Deal Amount
  • $372K

CancerVAX General Information

Description

Developer of immunotherapy cancer treatments designed to harness the body's immune system to recognize and destroy cancer cells. The company offers a platform that includes nanoparticle-based therapeutic candidates, gene-editing technologies, personalized CAR T-cell therapies, antibody treatments, and collaborations with research organizations for preclinical and clinical development, enabling oncology researchers and healthcare providers to advance innovative immunotherapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1633 West Innovation Way
  • 5th floor
  • Lehi, UT 84043
  • United States
+1 (805)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1633 West Innovation Way
  • 5th floor
  • Lehi, UT 84043
  • United States
+1 (805)

CancerVAX Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CancerVAX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Equity Crowdfunding 15-Jun-2026 $372K Announced Pre-Clinical Trials
5. Equity Crowdfunding 30-Apr-2026 Completed Pre-Clinical Trials
4. Early Stage VC 03-Apr-2024 Completed Pre-Clinical Trials
3. Early Stage VC 18-Oct-2024 Completed Pre-Clinical Trials
2. Equity Crowdfunding 08-Nov-2023 $833K $2.83M Completed Pre-Clinical Trials
1. Seed Round 30-Mar-2021 $2M $2M Completed Pre-Clinical Trials
To view CancerVAX’s complete valuation and funding history, request access »

CancerVAX Patents

CancerVAX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026030652-A1 Methods and compositions for cancer treatment Pending 31-Jul-2024
US-20240424094-A1 Methods and compositions for cancer treatment Pending 06-Oct-2021
WO-2023059606-A1 Methods and compositions for cancer treatment Inactive 06-Oct-2021 A61K39/39558

CancerVAX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CancerVAX FAQs

  • When was CancerVAX founded?

    CancerVAX was founded in 2021.

  • Where is CancerVAX headquartered?

    CancerVAX is headquartered in Lehi, UT.

  • What is the size of CancerVAX?

    CancerVAX has 6 total employees.

  • What industry is CancerVAX in?

    CancerVAX’s primary industry is Drug Discovery.

  • Is CancerVAX a private or public company?

    CancerVAX is a Private company.

  • What is the current valuation of CancerVAX?

    The current valuation of CancerVAX is .

  • What is CancerVAX’s current revenue?

    The current revenue for CancerVAX is .

  • How much funding has CancerVAX raised over time?

    CancerVAX has raised $9.7M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process